With the macroeconomic recovery worldwide, birth rates have started to improve substantially and are gradually returning to historical levels. Hospitals are again making the nursery and the NICU (neonatal intensive care unit) their priorities. This will result in more capital spending in this area in near future. The trend has just begun, and has a long way to go before any significant reversal. One company that is set to gain from this new trend is Natus Medical (NASDAQ:BABY), a global provider of newborn care products. Its shares rose as much as 40% after reporting its third-quarter earnings in October and I feel this is just the beginning.
In this investment thesis I will focus on BABY's opportunities
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|